Yahoo India Web Search

Search results

  1. Cardiovascular Diabetology is an open access journal that publishes original research on the diabetes/cardiovascular interrelationship and the metabolic syndrome. The journal covers clinical, genetic, experimental, pharmacological, epidemiological and molecular biology aspects of the field, and features editorials, reviews, highlights and blogs.

    • The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice. Type-2 diabetes (T2D) worsens stroke recovery, amplifying post-stroke disabilities.
    • Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study. Insulin resistance (IR) is involved in the pathophysiological processes of arrhythmias.
    • Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: NHANES longitudinal cohort study.
    • Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study.
    • High Visibility
    • Speed of Publication
    • Flexibility
    • Promotion and Press Coverage
    • Copyright
    • GeneratedCaptionsTabForHeroSec

    Cardiovascular Diabetology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.

    Cardiovascular Diabetologyoffers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acc...

    Online publication in Cardiovascular Diabetology gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to...

    Articles published in Cardiovascular Diabetology are included in article alerts and regular email updates. Some may be highlighted on Cardiovascular Diabetology’s pages and on the BMC homepage. In addition, articles published in Cardiovascular Diabetology may be promoted by press releases to the general or scientific press. These activities increas...

    As an author of an article published in Cardiovascular Diabetology you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement). For further information about the advantages of publishing in a journal from BMC, please click here.

    Cardiovascular Diabetology publishes articles on the link between diabetes and cardiovascular disorders, covering clinical, genetic, experimental, pharmacological, epidemiological and molecular biology research. The journal is fully open access, peer-reviewed, indexed in various databases and offers fast publication and high visibility.

  2. Cardiovascular Diabetology is an open access journal that publishes research on the link between diabetes and cardiovascular diseases. It covers clinical, genetic, experimental, pharmacological, epidemiological, and molecular biology studies to improve public health.

  3. Feb 21, 2019 · Cardiovascular disease remains a leading cause of morbidity and mortality in people with types 1 or 2 diabetes mellitus. Although beneficial roles for strict control of hyperglycemia have been suggested, such a strategy is not without liabilities.

    • Ann Marie Schmidt
    • 2019
  4. Cardiovascular Diabetology publishes peer-reviewed articles on the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome. It is a high-impact journal in the fields of cardiology, endocrinology and internal medicine, with a SJR of 2.621 in 2023.

  5. May 14, 2022 · Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low- and middle-income countries.